News

EIB supports Ghana’s Covid-19 Nat’l Response Plan with €82.5m

President Nana Addo Dankwa Akufo-Addo has welcomed the €82.5 million support offered to Ghana by the European Investment  Bank (EIB) to strengthen healthcare, provision of specialist medical equipment and medicines across Ghana under the national COVID-19 Health Response Plan. 

The concessional financing package, which comprises a €75 million facility from the  EIB, and €7.5 million grant from the European Commission, was signed at the Luxembourg Headquarters of the European Investment Bank, following President  Akufo-Addo’s official visit to Luxembourg on Monday, 13th December 2021. 

The new agreement with Ghana represents the largest national EIB financing for COVID related health investment in Africa. 

The new facility, representing the EIB’s largest support for COVID related health  investment in sub-Saharan Africa, was signed by one behalf of Ghana by Hon.  Kwaku Ampratwum-Sarpong, the Deputy Minister for Foreign Affairs, and Ambroise  Fayolle, European Investment Bank Vice President, in the presence of President Nana Akufo-Addo, EIB President Werner Hoyer and H.E. Sena Siaw-Boateng, Ambassador of Ghana to the European Union. 

“Strengthened cooperation between Africa and multilateral development partners is crucial to share global best practice and ensure a rapid response to health, social  and health challenges triggered by the COVID-19 pandemic. The European Investment Bank and the European Union are key partners for Ghana and I welcome their support for our national COVID-19 Health Response Plan,” President Akufo- Addo said. 

He continued, “Ghanaian and EIB experts have worked tirelessly in recent months to finalise this initiative since President Hoyer and I met earlier this year. Specialist healthcare and medical services will benefit from both the EIB’s largest backing for COVID health resilience in Africa and EU grant support”. 

About The Author

Related Articles

Check Also
Close
Back to top button

This website uses cookies. By continuing to use this site, you accept our use of cookies.